Evidence map›Paper›PMID 37274473›Full record

ArticleOncology letters2023

Prognostic value of E‑26 transformation‑specific‑related gene in prostate cancer based on immunohistochemistry analysis.

Yang Zhang, Jing Tao, Rangrang Wang, Haojie Xuan, Zhihao Chen, Li Xiao, Haiyong Ding, Zhongquan Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yang ZhangDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Jing TaoDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Rangrang WangDepartment of Surgery, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Haojie XuanDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Zhihao ChenDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Li XiaoDepartment of Pathology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Haiyong DingDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Zhongquan SunDepartment of Urology, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-26 transformation-specific-related gene (ERG) has been implicated in prostate cancer; however, its prognostic role remains unclear. Therefore, the present study aimed to investigate the association of ERG with the prognosis after radical prostatectomy in patients with prostate cancer. Patient data were collected at the Huadong Hospital, affiliated with Fudan University, between January 2016 and March 2020. ERG protein expression was detected using immunohistochemistry. Independent-sample t-tests and χ

Indexed as

biochemical recurrenceE-26 transformation-specific-related geneimmunohistochemistryprognosisprostate cancer

Identifiers

PMID37274473
PMCPMC10236269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.